Last reviewed · How we verify
Pancreas Liquescence (CHROMIUM)
At a glance
| Generic name | CHROMIUM |
|---|---|
| Sponsor | Nutritional Specialties, Inc. |
| Drug class | Standardized Chemical Allergen [EPC] |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Long-Term Periodontal Tissue Changes Associated With Metal-Ceramic Crowns: An 8-Year Split-Mouth Study (NA)
- A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China
- Comparison of Prosthetic Complications and Framework Misfit Among Different Cobalt-Chromium Framework Fabrication Techniques (NA)
- Metal Ion Concentrations After Total Knee Arthroplasty
- eUltra 10k - Biofreedom Ultra
- Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion (PHASE1)
- Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (NA)
- Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pancreas Liquescence CI brief — competitive landscape report
- Pancreas Liquescence updates RSS · CI watch RSS
- Nutritional Specialties, Inc. portfolio CI